Ranibizumab for myopic choroidal neovascularization
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2021.1830969
Abstract: ABSTRACT Introduction Myopic choroidal neovascularization (CNV) is one of the most vision-threatening complications in patients with pathologic myopia. Over the last decade, anti-angiogenesis therapy with anti-vascular endothelial growth factor (anti-VEGF) agents has become the standard-of-care… read more here.
Keywords: myopic; myopic cnv; ranibizumab myopic; myopic choroidal ... See more keywords